These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

297 related items for PubMed ID: 7606729

  • 1. Effect of aromatase inhibitors on growth of mammary tumors in a nude mouse model.
    Yue W, Wang J, Savinov A, Brodie A.
    Cancer Res; 1995 Jul 15; 55(14):3073-7. PubMed ID: 7606729
    [Abstract] [Full Text] [Related]

  • 2. A new nude mouse model for postmenopausal breast cancer using MCF-7 cells transfected with the human aromatase gene.
    Yue W, Zhou D, Chen S, Brodie A.
    Cancer Res; 1994 Oct 01; 54(19):5092-5. PubMed ID: 7923123
    [Abstract] [Full Text] [Related]

  • 3. Antitumor action of physiological estradiol on tamoxifen-stimulated breast tumors grown in athymic mice.
    Yao K, Lee ES, Bentrem DJ, England G, Schafer JI, O'Regan RM, Jordan VC.
    Clin Cancer Res; 2000 May 01; 6(5):2028-36. PubMed ID: 10815929
    [Abstract] [Full Text] [Related]

  • 4. Flaxseed alone or in combination with tamoxifen inhibits MCF-7 breast tumor growth in ovariectomized athymic mice with high circulating levels of estrogen.
    Chen J, Power KA, Mann J, Cheng A, Thompson LU.
    Exp Biol Med (Maywood); 2007 Sep 01; 232(8):1071-80. PubMed ID: 17720953
    [Abstract] [Full Text] [Related]

  • 5. Preclinical studies using the intratumoral aromatase model for postmenopausal breast cancer.
    Brodie A, Lu Q, Liu Y, Long B, Wang JP, Yue W.
    Oncology (Williston Park); 1998 Mar 01; 12(3 Suppl 5):36-40. PubMed ID: 9556790
    [Abstract] [Full Text] [Related]

  • 6. The effect of second-line antiestrogen therapy on breast tumor growth after first-line treatment with the aromatase inhibitor letrozole: long-term studies using the intratumoral aromatase postmenopausal breast cancer model.
    Long BJ, Jelovac D, Thiantanawat A, Brodie AM.
    Clin Cancer Res; 2002 Jul 01; 8(7):2378-88. PubMed ID: 12114443
    [Abstract] [Full Text] [Related]

  • 7. Predictions from a preclinical model: studies of aromatase inhibitors and antiestrogens.
    Brodie A, Jelovac D, Long BJ.
    Clin Cancer Res; 2003 Jan 01; 9(1 Pt 2):455S-9S. PubMed ID: 12538500
    [Abstract] [Full Text] [Related]

  • 8. Effects of the antiestrogen tamoxifen and the aromatase inhibitor letrozole on serum hormones and bone characteristics in a preclinical tumor model for breast cancer.
    Núñez NP, Jelovac D, Macedo L, Berrigan D, Perkins SN, Hursting SD, Barrett JC, Brodie A.
    Clin Cancer Res; 2004 Aug 15; 10(16):5375-80. PubMed ID: 15328175
    [Abstract] [Full Text] [Related]

  • 9. An antiangiogenic urokinase-derived peptide combined with tamoxifen decreases tumor growth and metastasis in a syngeneic model of breast cancer.
    Guo Y, Mazar AP, Lebrun JJ, Rabbani SA.
    Cancer Res; 2002 Aug 15; 62(16):4678-84. PubMed ID: 12183425
    [Abstract] [Full Text] [Related]

  • 10. Tamoxifen-resistant fibroblast growth factor-transfected MCF-7 cells are cross-resistant in vivo to the antiestrogen ICI 182,780 and two aromatase inhibitors.
    McLeskey SW, Zhang L, El-Ashry D, Trock BJ, Lopez CA, Kharbanda S, Tobias CA, Lorant LA, Hannum RS, Dickson RB, Kern FG.
    Clin Cancer Res; 1998 Mar 15; 4(3):697-711. PubMed ID: 9533540
    [Abstract] [Full Text] [Related]

  • 11. Effects of a new clinically relevant antiestrogen (GW5638) related to tamoxifen on breast and endometrial cancer growth in vivo.
    Dardes RC, O'Regan RM, Gajdos C, Robinson SP, Bentrem D, De Los Reyes A, Jordan VC.
    Clin Cancer Res; 2002 Jun 15; 8(6):1995-2001. PubMed ID: 12060645
    [Abstract] [Full Text] [Related]

  • 12. Effects of aromatase inhibitors, aminoglutethimide, and 4-hydroxyandrostenedione on cyclic rats and rats with 7,12-dimethylbenz(a)anthracene-induced mammary tumors.
    Wing LY, Garrett WM, Brodie AM.
    Cancer Res; 1985 Jun 15; 45(6):2425-8. PubMed ID: 3921242
    [Abstract] [Full Text] [Related]

  • 13. Differential responses of sex steroid target tissues of rats treated with 4-hydroxyandrostenedione.
    Wing LY, Hammond JO, Brodie AM.
    Endocrinology; 1988 Jun 15; 122(6):2418-27. PubMed ID: 3131115
    [Abstract] [Full Text] [Related]

  • 14. The effect of combining aromatase inhibitors with antiestrogens on tumor growth in a nude mouse model for breast cancer.
    Lu Q, Liu Y, Long BJ, Grigoryev D, Gimbel M, Brodie A.
    Breast Cancer Res Treat; 1999 Sep 15; 57(2):183-92. PubMed ID: 10598045
    [Abstract] [Full Text] [Related]

  • 15. Differential response of an ovarian-responsive mouse mammary tumor to androgenic and estrogenic agents.
    Matsuzawa A, Ikeda Y.
    Cancer Res; 1983 Aug 15; 43(8):3680-6. PubMed ID: 6861137
    [Abstract] [Full Text] [Related]

  • 16. Dietary flaxseed enhances the inhibitory effect of tamoxifen on the growth of estrogen-dependent human breast cancer (mcf-7) in nude mice.
    Chen J, Hui E, Ip T, Thompson LU.
    Clin Cancer Res; 2004 Nov 15; 10(22):7703-11. PubMed ID: 15570004
    [Abstract] [Full Text] [Related]

  • 17. Contrasting actions of tamoxifen on endometrial and breast tumor growth in the athymic mouse.
    Gottardis MM, Robinson SP, Satyaswaroop PG, Jordan VC.
    Cancer Res; 1988 Feb 15; 48(4):812-5. PubMed ID: 3338079
    [Abstract] [Full Text] [Related]

  • 18. Effects of aromatase inhibitor 4-hydroxyandrostenedione and other compounds in the 7, 12-dimethylbenz(a)anthracene-induced breast carcinoma model.
    Brodie AM, Garrett WM, Hendrickson JR, Tsai-Morris CH.
    Cancer Res; 1982 Aug 15; 42(8 Suppl):3360s-3364s. PubMed ID: 6805949
    [Abstract] [Full Text] [Related]

  • 19. Dietary flaxseed interaction with tamoxifen induced tumor regression in athymic mice with MCF-7 xenografts by downregulating the expression of estrogen related gene products and signal transduction pathways.
    Chen J, Power KA, Mann J, Cheng A, Thompson LU.
    Nutr Cancer; 2007 Aug 15; 58(2):162-70. PubMed ID: 17640162
    [Abstract] [Full Text] [Related]

  • 20. Antitumor effects of a nonsteroidal aromatase inhibitor (CGS 16949A) on 7, 12-dimethylbenz[alpha]anthracene-induced mammary tumors in rats.
    Iino Y, Sugamata N, Owada S, Tago T, Sato H, Yokoe T, Maemura M, Morishita Y, Horiuchi R.
    Jpn J Clin Oncol; 1991 Jun 15; 21(3):153-9. PubMed ID: 1834875
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.